Studies using colon cancer cells (HCT116) revealed that genistein-mediated antimetastatic effects via inhibition of COX-2 and MMP-9, Ang-1, vasodilator-stimulated phosphoprotein (VASP) and VEGF (Kang et al., 2018). The gene discussed is VASP; the disease is colonic neoplasm.